(Q41253203)

28 September 2017

1 reference

title

Current aspects of drug therapy in Philadelphia-positive CML: correlation of tumor burden with survival (English)

1 reference

28 September 2017

Hehlmann R

1

1 reference

28 September 2017

Heimpel H

series ordinal

2

1 reference

28 September 2017

publication date

1 September 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

22 Suppl 1

1 reference

28 September 2017

page(s)

161-167

1 reference

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

Karyotypic conversion in Ph1-positive chronic myeloid leukaemia with combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

Hydroxyurea therapy in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

Interferon in chronic myeloid leukemia. A workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

Intensive combination chemotherapy and interferons in the management of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609074374

10.3109/10428199609074374

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference